Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Fibroblast growth factor 23 expression in human calcified vascular tissues.

Donate-Correa J, Martín-Núñez E, Hernández-Carballo C, Ferri C, Tagua VG, Delgado-Molinos A, López-Castillo Á, Rodríguez-Ramos S, Cerro-López P, López-Tarruella VC, Felipe-García R, Arévalo-Gomez MA, Pérez-Delgado N, Mora-Fernández C, Navarro-González JF.

Aging (Albany NY). 2019 Sep 22;11(18):7899-7913. doi: 10.18632/aging.102297. Epub 2019 Sep 22.

2.

FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus.

Donate-Correa J, Martín-Núñez E, Ferri C, Hernández-Carballo C, Tagua VG, Delgado-Molinos A, López-Castillo Á, Rodríguez-Ramos S, Cerro-López P, López-Tarruella VC, Arévalo-González MA, Pérez-Delgado N, Mora-Fernández C, Navarro-González JF.

J Clin Med. 2019 Apr 3;8(4). pii: E448. doi: 10.3390/jcm8040448.

3.

Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons.

Donate-Correa J, Tagua VG, Ferri C, Martín-Núñez E, Hernández-Carballo C, Ureña-Torres P, Ruiz-Ortega M, Ortiz A, Mora-Fernández C, Navarro-González JF.

J Clin Med. 2019 Feb 27;8(3). pii: E287. doi: 10.3390/jcm8030287. Review.

4.

Inflammation in Diabetic Kidney Disease.

Pérez-Morales RE, Del Pino MD, Valdivielso JM, Ortiz A, Mora-Fernández C, Navarro-González JF.

Nephron. 2019;143(1):12-16. doi: 10.1159/000493278. Epub 2018 Oct 1. Review.

5.

Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease.

Navarro-González JF, Sánchez-Niño MD, Donate-Correa J, Martín-Núñez E, Ferri C, Pérez-Delgado N, Górriz JL, Martínez-Castelao A, Ortiz A, Mora-Fernández C.

Diabetes Care. 2018 Aug;41(8):1817-1820. doi: 10.2337/dc18-0078. Epub 2018 Jun 4.

PMID:
29866645
6.

Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease.

Martín-Núñez E, Donate-Correa J, López-Castillo Á, Delgado-Molinos A, Ferri C, Rodríguez-Ramos S, Cerro P, Pérez-Delgado N, Castro V, Hernández-Carballo C, Mora-Fernández C, Navarro-González JF.

Clin Sci (Lond). 2017 Oct 25;131(21):2601-2609. doi: 10.1042/CS20171242. Print 2017 Nov 1.

PMID:
28963437
7.

Anti-inflammatory profile of paricalcitol in kidney transplant recipients.

Donate-Correa J, Henríquez-Palop F, Martín-Núñez E, Hernández-Carballo C, Ferri C, Pérez-Delgado N, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF.

Nefrologia. 2017 Nov - Dec;37(6):622-629. doi: 10.1016/j.nefro.2017.03.028. Epub 2017 Jun 15. English, Spanish.

8.

Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant Recipients.

Donate-Correa J, Henríquez-Palop F, Martín-Núñez E, Pérez-Delgado N, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF.

Transplantation. 2016 Nov;100(11):2432-2438.

PMID:
27467536
9.

Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes.

Donate-Correa J, Martín-Núñez E, Delgado NP, de Fuentes MM, Arduan AO, Mora-Fernández C, Navarro González JF.

Cytokine Growth Factor Rev. 2016 Apr;28:71-7. doi: 10.1016/j.cytogfr.2015.12.003. Epub 2015 Dec 10. Review.

PMID:
26706229
10.

Klotho in cardiovascular disease: Current and future perspectives.

Donate-Correa J, Martín-Núñez E, Mora-Fernández C, Muros-de-Fuentes M, Pérez-Delgado N, Navarro-González JF.

World J Biol Chem. 2015 Nov 26;6(4):351-7. doi: 10.4331/wjbc.v6.i4.351. Review.

11.

Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease.

Donate-Correa J, Martín-Núñez E, Martínez-Sanz R, Muros-de-Fuentes M, Mora-Fernández C, Pérez-Delgado N, Navarro-González JF.

J Cell Mol Med. 2016 Jan;20(1):128-33. doi: 10.1111/jcmm.12710. Epub 2015 Nov 5.

12.

Inflammatory cytokines in diabetic nephropathy.

Donate-Correa J, Martín-Núñez E, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF.

J Diabetes Res. 2015;2015:948417. doi: 10.1155/2015/948417. Epub 2015 Feb 15. Review.

13.

Implications of Klotho in vascular health and disease.

Martín-Núñez E, Donate-Correa J, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF.

World J Cardiol. 2014 Dec 26;6(12):1262-9. doi: 10.4330/wjc.v6.i12.1262. Review.

14.

Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial.

Navarro-González JF, Mora-Fernández C, Muros de Fuentes M, Chahin J, Méndez ML, Gallego E, Macía M, del Castillo N, Rivero A, Getino MA, García P, Jarque A, García J.

J Am Soc Nephrol. 2015 Jan;26(1):220-9. doi: 10.1681/ASN.2014010012. Epub 2014 Jun 26.

15.

Diabetic kidney disease: from physiology to therapeutics.

Mora-Fernández C, Domínguez-Pimentel V, de Fuentes MM, Górriz JL, Martínez-Castelao A, Navarro-González JF.

J Physiol. 2014 Sep 15;592(18):3997-4012. doi: 10.1113/jphysiol.2014.272328. Epub 2014 Jun 6. Review.

16.

Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney disease.

Donate-Correa J, Domínguez-Pimentel V, Muros-de-Fuentes M, Mora-Fernández C, Martín-Núñez E, Cazaña-Pérez V, Navarro-González JF.

Curr Drug Targets. 2014;15(7):703-9. Review.

PMID:
24745821
17.

Reduced Klotho is associated with the presence and severity of coronary artery disease.

Navarro-González JF, Donate-Correa J, Muros de Fuentes M, Pérez-Hernández H, Martínez-Sanz R, Mora-Fernández C.

Heart. 2014 Jan;100(1):34-40. doi: 10.1136/heartjnl-2013-304746. Epub 2013 Oct 28.

PMID:
24165855
18.

Pathophysiological implications of fibroblast growth factor-23 and Klotho and their potential role as clinical biomarkers.

Donate-Correa J, Muros de Fuentes M, Mora-Fernández C, Navarro-González JF.

Clin Chem. 2014 Jul;60(7):933-40. doi: 10.1373/clinchem.2013.206649. Epub 2013 Jun 11. Review.

19.

Anti-inflammatory profile of paricalcitol in hemodialysis patients: a prospective, open-label, pilot study.

Navarro-González JF, Donate-Correa J, Méndez ML, de Fuentes MM, García-Pérez J, Mora-Fernández C.

J Clin Pharmacol. 2013 Apr;53(4):421-6. doi: 10.1002/jcph.19. Epub 2013 Feb 20.

PMID:
23426718
20.

[Fibroblast growth factor 23/Klotho system in the context of cardiovascular damage].

Donate-Correa J, Muros-de-Fuentes M, Mora-Fernández C, Navarro-González JF.

Med Clin (Barc). 2013 May 4;140(9):420-3. doi: 10.1016/j.medcli.2012.11.010. Epub 2013 Jan 18. Review. Spanish. No abstract available.

PMID:
23337450

Supplemental Content

Loading ...
Support Center